share_log

Needham Reiterates Buy on Hologic, Maintains $90 Price Target

Benzinga ·  Dec 19 19:57  · Ratings

Needham analyst Mike Matson reiterates Hologic (NASDAQ:HOLX) with a Buy and maintains $90 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment